Table of Contents Table of Contents
Previous Page  43 / 58 Next Page
Information
Show Menu
Previous Page 43 / 58 Next Page
Page Background

1.- Le DT, et al. J Clin Oncol 2015;

OS, 1º endpoint

Rand P II

1

:

GVAX+CRS207 vs GVAX

CRS207

Rand

P.II

ECLIPSE

NCT 02004262

Adv Panc Canc 2nd line

1º endpoint OS

GVAX+CRS207

QT

OS

(median )

3.8 m

p NS

5.4 m

p NS

4,6 m

P.II

STELLAR

Adv Panc Canc

GVAX+CRS207+Nivolumab